News
Featured news
Latest news
IDIBAPS creates the research group “Neuroimmunological crosstalk in infections and brain autoimmunity (ImmuBRAIN)”
The IDIBAPS Steering Committee has approved the creation of the new research group, which is led by Marianna Spatola, an R3B researcher, who until...
Europe’s largest study reveals a high prevalence of undiagnosed liver fibrosis
Liver fibrosis results from chronic liver damage and can progress silently over many years, without obvious symptoms, until liver injury becomes ir...
Prediabetes: early detection and prevention of type 2 diabetes
The identification of individuals with prediabetes, together with recommendations for dietary and lifestyle changes, can help prevent the onset of...
A Clínic-IDIBAPS study discovers that nanoparticles with DNA enhance the effect of immunotherapy against cancer
A study co-led by Sònia Guedan, head of the IDIBAPS Cellular immunotherapies for cancer group, has shown in various animal cancer models that the...
A simple model makes it possible to predict which patients experiencing a first psychotic episode will recover during the first year
A multicentre team, led by Sergi Mas, lecturer in the Pharmacology Unit of the Department of Clinical Foundations at the Faculty of Medicine and He...
